(R)-1-((5E,8E)-5,8-bis(hydroxyimino)-1,4-dimethoxy-5,8-dihydronaphthalen-2-yl)-4-methylpent-3-en-1-yl propionate | 1622443-37-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: (R)-1-((5E,8E)-5,8-bis(hydroxyimino)-1,4-dimethoxy-5,8-dihydronaphthalen-2-yl)-4-methylpent-3-en-1-yl propionate
• CAS: 1622443-37-1
• 化学式: C₂₁H₂₆N₂O₆
• 分子量: 402.447
• InChiKey: RNUSMVJCGOEGTO-GWIYHKIPSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.98
• 重原子数：
  29.0
• 可旋转键数：
  7.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  109.94
• 氢给体数：
  2.0
• 氢受体数：
  8.0

反应信息

• 作为产物：
  描述：

  (R)-4-methyl-1-(1,4,5,8-tetramethoxynaphthalen-2-yl)pent-3-en-1-ol 在 吡啶 、 4-二甲氨基吡啶 、 ammonium cerium (IV) nitrate 、 盐酸羟胺 、 N,N'-二环己基碳二亚胺 作用下， 以 乙醇 、 二氯甲烷 、 水 为溶剂， 反应 0.25h， 生成 (R)-1-((5E,8E)-5,8-bis(hydroxyimino)-1,4-dimethoxy-5,8-dihydronaphthalen-2-yl)-4-methylpent-3-en-1-yl propionate
  参考文献：
  名称：

  Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents

  摘要：

  A set of forty alkannin and shikonin oxime derivatives were firstly designed and synthesized. Their cytotoxicities against three kinds of tumor cells and a normal cell line were tested and compared with alkannin and shikonin. The cell-based investigation demonstrated that some oxime derivatives were more or comparatively effective to the lead compounds, especially their selective and excellent antitumor activities towards K562 cells with no toxicity in normal cells. We may conclude that oximate modification to the mother nucleus of alkannin and shikonin is an available approach to acquire potent antitumor agents.

  DOI：

  10.1016/j.bmcl.2014.07.012

文献信息

• SHIKONIN, ALKANNIN; AND RACEMIC PARENT NUCLEUS CABONYL OXIME DERIVATIVES AND APPLICATIONS THEREOF
  申请人：SHANGHAI JIAO TONG UNIVERSITY

  公开号：US20150344415A1

  公开（公告）日：2015-12-03

  A structural formula of a shikonin naphthazarin parent nucleus hydroxyl methylation carbonyl oxime derivative is shown in Formula (I) or (II); a structural formula of an alkannin naphthazarin parent nucleus hydroxyl methylation carbonyl oxime derivative is shown in Formula (III) or (IV); and a structural formula of a racemic shikonin naphthazarin parent nucleus hydroxyl methylation carbonyl oxime derivative is shown in Formula (V) or (VI), wherein R1 is alkane, olefin, arene, or substituting arene comprising 1 to 6 carbon atoms; and R2 is alkane, olefin, arene, or substituting arene comprising 1 to 6 carbon atoms or is H. The shikonin, alkannin, and racemic oxime derivatives of the present invention have novel structures, and in-vitro experiments show that the present invention has good growth inhibitory activity against tumor cells and can be used in tumor treatment.

  该申请的新颖结构的芪酮、茜草酮和消旋肟衍生物的结构式如下：芪酮萘酚基亚甲基羟甲基羰基肟衍生物的结构式为（I）或（II）；茜草酮萘酚基亚甲基羟甲基羰基肟衍生物的结构式为（III）或（IV）；消旋芪酮萘酚基亚甲基羟甲基羰基肟衍生物的结构式为（V）或（VI），其中R1是烷烃、烯烃、芳烃或含有1至6个碳原子的取代芳烃；R2是烷烃、烯烃、芳烃或含有1至6个碳原子的取代芳烃，或者是氢。该发明的芪酮、茜草酮和消旋肟衍生物具有新颖的结构，在体外实验中显示出对肿瘤细胞有良好的生长抑制活性，并可用于肿瘤治疗。
• US9630912B2
  申请人：——

  公开号：US9630912B2

  公开（公告）日：2017-04-25